Bio-Techne (TECH) Finished Goods (2010 - 2026)
Bio-Techne's quarterly Finished Goods came in at $111.9 million in Q1 2026, down 1.25% year-on-year from $113.3 million in Q1 2025, and down 2.57% quarter-over-quarter from $114.8 million in Q4 2025.
Bio-Techne has reported Finished Goods for 16 years, with the latest figure at $111.9 million in Q1 2026.
- For the quarter ending Q1 2026, Finished Goods fell 1.25% year-over-year to $111.9 million; the trailing twelve-month figure through Mar 2026 stood at $111.9 million (down 1.25% YoY), and the FY2025 full-year result was $106.2 million, changed 0.11% from the prior year.
- Finished Goods for Q1 2026 stood at $111.9 million, down from $114.8 million in the prior quarter.
- The five-year high for Finished Goods was $114.9 million in Q3 2025, with the low at $66.9 million in Q2 2022.
- Average Finished Goods over 5 years is $100.4 million, with a median of $106.1 million recorded in 2024.
- Year-over-year, Finished Goods soared 38.14% in 2023 and retreated 1.25% in 2026.
- Tracing TECH's Finished Goods over 5 years: stood at $80.5 million in 2022, then advanced by 27.76% to $102.9 million in 2023, then advanced by 7.04% to $110.2 million in 2024, then rose by 4.26% to $114.8 million in 2025, then decreased by 2.57% to $111.9 million in 2026.
- The last three Finished Goods figures came in at $111.9 million (Q1 2026), $114.8 million (Q4 2025), and $114.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.89 Mn |
| Dec 31, 2025 | 114.84 Mn |
| Sep 30, 2025 | 114.88 Mn |
| Jun 30, 2025 | 106.19 Mn |
| Mar 31, 2025 | 113.31 Mn |
| Dec 31, 2024 | 110.15 Mn |
| Sep 30, 2024 | 108.81 Mn |
| Jun 30, 2024 | 106.07 Mn |
| Mar 31, 2024 | 104.38 Mn |
| Dec 31, 2023 | 102.91 Mn |
| Sep 30, 2023 | 106.54 Mn |
| Jun 30, 2023 | 92.47 Mn |
| Mar 31, 2023 | 88.04 Mn |
| Dec 31, 2022 | 80.55 Mn |
| Sep 30, 2022 | 78.18 Mn |
| Jun 30, 2022 | 66.94 Mn |
| Jun 30, 2021 | 67.11 Mn |
| Mar 31, 2019 | 56.66 Mn |
| Dec 31, 2018 | 55.65 Mn |
| Sep 30, 2018 | 58.84 Mn |
| Jun 30, 2018 | 54.69 Mn |
| Mar 31, 2018 | 59.17 Mn |
| Dec 31, 2017 | 42.88 Mn |
| Sep 30, 2017 | 42.00 Mn |
| Jun 30, 2017 | 54.69 Mn |
| Mar 31, 2017 | 41.11 Mn |
| Dec 31, 2016 | 43.89 Mn |
| Sep 30, 2016 | 50.95 Mn |
| Jun 30, 2016 | 38.42 Mn |
| Mar 31, 2016 | 34.45 Mn |
| Dec 31, 2015 | 35.25 Mn |
| Sep 30, 2015 | 36.09 Mn |
| Jun 30, 2015 | 33.69 Mn |
| Mar 31, 2015 | 35.34 Mn |
| Dec 31, 2014 | 36.81 Mn |
| Sep 30, 2014 | 36.85 Mn |
| Jun 30, 2014 | 29.00 Mn |
| Mar 31, 2014 | 29.31 Mn |
| Dec 31, 2013 | 30.87 Mn |
| Sep 30, 2013 | 31.58 Mn |
| Jun 30, 2013 | 28.99 Mn |
| Mar 31, 2013 | 29.66 Mn |
| Dec 31, 2012 | 31.75 Mn |
| Sep 30, 2012 | 32.58 Mn |
| Jun 30, 2012 | 32.60 Mn |
| Mar 31, 2012 | 35.07 Mn |
| Dec 31, 2011 | 35.52 Mn |
| Sep 30, 2011 | 36.66 Mn |
| Jun 30, 2011 | 39.26 Mn |
| Jun 30, 2010 | 8.30 Mn |